Take U.S., as an example, please explain why small/mid-sized brand-name pharmas can prosper. But there are no small generic pharmas. I'm talking about generic drug maker, not distributors or those that acquire non-strategic assets from big pharmas.
I have worked in this field 20+ years in various capacities . .
Take U.S., as an example, please explain why small/mid-sized brand-name pharmas can prosper. But there are no small generic pharmas. I'm talking about generic drug maker, not distributors or those that acquire non-strategic assets from big pharmas.
所有跟帖:
• haha, what you said is exactly just why you do not know. You don -MICKEY222- ♀ (113 bytes) () 03/27/2013 postreply 07:11:24
• Haha, look at the deal between Sirtris and GSK . . . -Fatcat999- ♂ (297 bytes) () 03/27/2013 postreply 07:27:30